Status:
TERMINATED
Prognostic Assessment of Contrast Echocardiography (PACE Study)
Lead Sponsor:
Acusphere
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of ...
Detailed Description
This observational study will investigate the ability of AI-700 contrast ECHO to predict risk of future cardiovascular events occurring in patients who had a recent history of chest pain at the time o...
Eligibility Criteria
Inclusion
- Eligible patients were enrolled in either AI-700-32 or AI-700-33.
Exclusion
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
773 Patients enrolled
Trial Details
Trial ID
NCT00670332
Start Date
July 1 2007
Last Update
May 1 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acusphere
Watertown, Massachusetts, United States, 02472